Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reduced Apaf-1 expression in human cutaneous melanomas.

D L Dai1, M Martinka, J A Bush

  • 11Department of Medicine, Division of Dermatology, Vancouver Hospital and Health Sciences Centre, University of British Columbia, Vancouver, BC, Canada V6H 3Z6.

British Journal of Cancer
|August 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting stature from knee height in Chinese elderly subjects.

Asia Pacific journal of clinical nutrition·2014
Same author

Nuclear ING2 expression is reduced in human cutaneous melanomas.

British journal of cancer·2006
Same author

[Clinical evaluation and immunomodulatory study of cefodizime].

Zhonghua nei ke za zhi·1999
Same author

[Assessment of nutrition in dialysis patients and chronic uremic patients].

Zhonghua nei ke za zhi·1999
Same author

Attitudes toward the mentally ill in a sample of professionals working in a psychiatric hospital in Beijing (China).

The International journal of social psychiatry·1999
Same author

Hodgkin's disease: immunoglobulin heavy and light chain gene rearrangements revealed in single Hodgkin/Reed-Sternberg cells.

Molecular pathology : MP·1999
Same journal

De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

British journal of cancer·2026
Same journal

Planetary Health Diet Index and breast cancer risk.

British journal of cancer·2026
Same journal

Can national lung cancer screening programs be implemented without exacerbating social disparities?

British journal of cancer·2026
Same journal

Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

British journal of cancer·2026
Same journal

Circulating metabolite biomarkers associated with prostate cancer risk in Black Americans: findings from the Southern Community Cohort Study.

British journal of cancer·2026
Same journal

Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use.

British journal of cancer·2026
See all related articles

Apoptosis Factor-1 (Apaf-1) expression is significantly reduced in malignant melanoma, a deadly skin cancer. Restoring Apaf-1 may enhance sensitivity to cancer drug treatments, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Malignant melanoma is a dangerous skin cancer known for metastasis and treatment resistance.
  • Evasion of apoptosis (programmed cell death) is crucial for melanoma growth, but the underlying mechanisms are not fully understood.
  • While p53 mutations are common in cancers, they are infrequent in melanoma, suggesting other apoptotic pathway failures.

Purpose of the Study:

  • To investigate the role of Apoptosis Factor-1 (Apaf-1) in melanoma progression.
  • To determine if reduced Apaf-1 expression is associated with malignant melanoma development.
  • To explore Apaf-1 as a potential therapeutic target for melanoma.

Main Methods:

  • Utilized tissue microarray technology to analyze Apaf-1 expression in 70 human primary malignant melanoma biopsies.

Related Experiment Videos

  • Employed immunohistochemistry to quantify Apaf-1 levels.
  • Conducted in vitro apoptosis assays to assess the impact of Apaf-1 overexpression on drug sensitivity.

    • Main Results:

    • Apaf-1 expression was found to be significantly reduced in melanoma cells compared to normal nevi.
    • Loss of Apaf-1 expression did not correlate with tumor thickness, ulceration, subtype, patient gender, age, or survival.
    • Overexpression of Apaf-1 in melanoma cells increased their sensitivity to anticancer drugs in vitro.

    Conclusions:

    • Apaf-1 expression is significantly downregulated in human malignant melanoma.
    • Apaf-1 inactivation may contribute to melanoma progression.
    • Apaf-1 represents a promising therapeutic target for melanoma treatment.